218 related articles for article (PubMed ID: 11709778)
1. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.
Peebles RS; Hashimoto K; Collins RD; Jarzecka K; Furlong J; Mitchell DB; Sheller JR; Graham BS
J Infect Dis; 2001 Dec; 184(11):1374-9. PubMed ID: 11709778
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.
Peebles RS; Sheller JR; Collins RD; Jarzecka AK; Mitchell DB; Parker RA; Graham BS
J Med Virol; 2001 Feb; 63(2):178-88. PubMed ID: 11170055
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
4. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion.
Cho JY; Miller M; Baek KJ; Castaneda D; Nayar J; Roman M; Raz E; Broide DH
J Allergy Clin Immunol; 2001 Nov; 108(5):697-702. PubMed ID: 11692091
[TBL] [Abstract][Full Text] [Related]
6. Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes.
Schwarze J; Mäkelä M; Cieslewicz G; Dakhama A; Lahn M; Ikemura T; Joetham A; Gelfand EW
J Immunol; 1999 Nov; 163(10):5729-34. PubMed ID: 10553105
[TBL] [Abstract][Full Text] [Related]
7. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.
Barends M; Van Oosten M; De Rond CG; Dormans JA; Osterhaus AD; Neijens HJ; Kimman TG
J Infect Dis; 2004 May; 189(10):1866-72. PubMed ID: 15122523
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus-induced exaggeration of allergic airway disease is dependent upon CCR1-associated immune responses.
John AE; Gerard CJ; Schaller M; Miller AL; Berlin AA; Humbles AA; Lukacs NW
Eur J Immunol; 2005 Jan; 35(1):108-16. PubMed ID: 15593301
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses.
Liu B; Kimura Y
J Med Virol; 2007 Oct; 79(10):1600-5. PubMed ID: 17705182
[TBL] [Abstract][Full Text] [Related]
10. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness.
Schwarze J; Cieslewicz G; Joetham A; Ikemura T; Hamelmann E; Gelfand EW
J Immunol; 1999 Apr; 162(7):4207-11. PubMed ID: 10201948
[TBL] [Abstract][Full Text] [Related]
11. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
[TBL] [Abstract][Full Text] [Related]
12. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization.
Schwarze J; Cieslewicz G; Joetham A; Ikemura T; Mäkelä MJ; Dakhama A; Shultz LD; Lamers MC; Gelfand EW
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):380-6. PubMed ID: 10934057
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma.
Barends M; Boelen A; de Rond L; Dormans J; Kwakkel J; van Oosten M; Neijens HJ; Kimman TG
J Med Virol; 2003 Jan; 69(1):156-62. PubMed ID: 12436492
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation.
John AE; Berlin AA; Lukacs NW
Eur J Immunol; 2003 Jun; 33(6):1677-85. PubMed ID: 12778486
[TBL] [Abstract][Full Text] [Related]
16. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection.
Schwarze J; Cieslewicz G; Hamelmann E; Joetham A; Shultz LD; Lamers MC; Gelfand EW
J Immunol; 1999 Mar; 162(5):2997-3004. PubMed ID: 10072551
[TBL] [Abstract][Full Text] [Related]
17. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
[TBL] [Abstract][Full Text] [Related]
18. Type 4 phosphodiesterase inhibitors attenuate respiratory syncytial virus-induced airway hyper-responsiveness and lung eosinophilia.
Ikemura T; Schwarze J; Makela M; Kanehiro A; Joetham A; Ohmori K; Gelfand EW
J Pharmacol Exp Ther; 2000 Aug; 294(2):701-6. PubMed ID: 10900250
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV.
Peebles RS; Sheller JR; Collins RD; Jarzecka K; Mitchell DB; Graham BS
J Infect Dis; 2000 Sep; 182(3):671-7. PubMed ID: 10950758
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.
Schwarze J; Hamelmann E; Bradley KL; Takeda K; Gelfand EW
J Clin Invest; 1997 Jul; 100(1):226-33. PubMed ID: 9202075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
